AIP Insider Filing: 3,660 Shares via Morgan Stanley, 10b5-1 Activity Listed

Rhea-AI Filing Summary

Arteris, Inc. (AIP) Form 144 reports a proposed sale of 3,660 common shares with an aggregate market value of $31,439.40, scheduled approximately for 09/09/2025 through NASDAQ by broker Morgan Stanley Smith Barney LLC. The shares were acquired as Restricted Stock Units from the issuer on 04/01/2025. The filing lists prior sales by the same person, Nicholas Hawkins, including multiple 10b5-1 plan transactions from 06/25/2025 through 09/02/2025 totaling several tens of thousands of shares and proceeds shown per trade.

Positive

• Detailed disclosure of proposed sale amount, acquisition date, broker, and market value
• Prior 10b5-1 sales are listed, indicating use of pre-established trading plans and transparency

Negative

• Frequent insider sales are documented across June–September 2025, which some investors may view unfavorably
• Filer identity and contact fields appear incomplete in the header section of the filing

Insights

Securities Analyst

TL;DR: Routine insider sale filing; modest share amount and clear 10b5-1 activity suggest preplanned dispositions rather than ad hoc liquidation.

The Form 144 discloses a proposed sale of 3,660 shares valued at $31,439.40 and confirms acquisition as RSUs on 04/01/2025. The filing names Morgan Stanley Smith Barney as broker and documents multiple prior 10b5-1 plan sales across June–September 2025, indicating an ongoing scheduled selling program. For investors this is a transparency filing rather than new corporate action; the absolute size of the proposed sale is small relative to the reported outstanding shares of 42,649,917.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 requirements; repeated 10b5-1 entries demonstrate compliance with planned insider sales.

The notice includes required representations about material nonpublic information and cites a 10b5-1 sales plan for multiple past transactions by the same insider. The clear dating of RSU acquisition and listed broker details support regulatory compliance. The filing does not disclose any undisclosed corporate events or governance changes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3660	31439.40	42649917	09/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2025	Restricted Stock Units	Issuer			3660	04/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	09/02/2025	438	3872.66
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/05/2025	11276	148285.04
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	08/01/2025	5638	50926.93
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/29/2025	5638	59206.33
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/07/2025	4948	45624.02
NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/02/2025	3889	34971.44
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/01/2025	5638	51196.42
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/27/2025	5638	56380.00
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/26/2025	5638	54970.50
10b5-1 Sales Plan for NICHOLAS HAWKINS 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/25/2025	5638	53561.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being sold in the Arteris (AIP) Form 144?

The filing proposes sale of 3,660 common shares with aggregate market value of $31,439.40.

When were the shares to be sold and on which exchange?

The approximate date of sale is listed as 09/09/2025 and the securities exchange is NASDAQ.

How were the shares acquired that are now being sold?

The shares were acquired as Restricted Stock Units (RSUs) from the issuer on 04/01/2025.

Who is the broker handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC with an address at 1 New York Plaza, 8th Floor, New York, NY 10004.

Has the filer sold related shares recently?

Yes. The filing lists multiple sales by Nicholas Hawkins from 06/25/2025 to 09/02/2025, including numerous 10b5-1 plan transactions and corresponding gross proceeds per trade.